ShiftPixy, Inc.: Nasdaq/NYSE listing notice — ShiftPixy receives Nasdaq non-compliance notice for July 2023 offering; 45 days to respond

ShiftPixy, Inc.

Received Nasdaq Staff letter on March 28, 2024, for failing to obtain shareholder approval under Rule 5635(d) for July 2023 best-efforts offering.
Offering of 2,066,667 units at $1.50 per unit represented >20% of outstanding shares; one investor bought 96%.
Staff determined offering was not a 'public offering' due to placement agency A.G.P./Alliance Global Partners and concentrated purchaser.
Company has 45 calendar days to submit a compliance plan; no immediate delisting effect.
If plan accepted, Nasdaq may grant up to 180-day extension to evidence compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ShiftPixy, Inc. received a nasdaq noncompliance notice notice regarding other (rules 5635(d)).

Exchange: nasdaq
Notice: noncompliance notice
Rules: 5635(d)

Exact text from the filing

March 28, 2024, ShiftPixy, Inc. (the “Company”) received a letter (the “Nasdaq Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notifies the Company that the Staff has determined that the Company failed to comply with Nasdaq’s shareholder approval requirements set forth in Listing Rule 5635(d),1 which requires prior shareholder approval for transactions, other than public offerings, involving the issuance of 20% or more of the pre-transaction shares outstanding at less than the Minimum Price. As set forth in the let

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001477932-24-001613

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.